Inovio Biomedical Financial Statements
Inovio Biomedical Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Inovio Biomedical Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 4.8 | 3.5 | 5.5 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (15.9) | (13.4) | (15.5) |
| Total Net Income ($ mil.) | (11.2) | (12.5) | (15.3) |
| Diluted EPS (Net Income) | (0.27) | (0.46) | (1.39) |
Inovio Biomedical Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.7 | 0.6 | 3.3 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (4.1) | (3.3) | (1.8) |
| Total Net Income ($ mil.) | (4.0) | (3.0) | 2.0 |
| Diluted EPS (Net Income) | (0.09) | (0.07) | 0.05 |
Inovio Biomedical Stock Quote & Chart
11/21/08 15:59:17 EST •
AMEX •
0.18
•
 -0.0195
•
-9.7500 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Inovio Biomedical Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 9.08 | 2.12 | 1.53 |
| Price/Earnings Ratio | -- | 21.54 | 15.41 |
| Price/Book Ratio | 1.97 | 2.23 | 1.46 |
| Price/Cash Flow Ratio | -- | 15.81 | 9.51 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Inovio Biomedical Financial Ratios
Inovio Biomedical Competitive Intelligence
| Introgen Therapeutics | Targeted Genetics | Vical | |
|---|---|---|---|
| Annual Sales ($ mil.) | 1.0 | 10.3 | 5.5 |
| Employees | -- | -- | -- |
| Market Cap ($ mil.) | 38.7 | 13.8 | 136.0 |
Competitive Landscape
